ULBP6/RAET1L is an additional human NKG2D ligand

European Journal of Immunology

Volumn 39, Issue 11, 2009, Pages 3207-3216

  Eagle, Robert A ^a   Traherne, James A ^a   Hair, James R ^a,c   Jafferji, Insiya ^a   Trowsdale, John ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UCB PHARMA   (Belgium)

Author keywords

Immune evasion; Infectious diseases; Innate immunity; NK cells; NK cell ligands

Indexed keywords

BINDING PROTEIN; NATURAL KILLER CELL RECEPTOR NKG2D; RECOMBINANT PROTEIN; UL16 BINDING PROTEIN 4; UL16 BINDING PROTEIN 5; UL16 BINDING PROTEIN 6; UNCLASSIFIED DRUG;

ARTICLE; CARCINOMA CELL; CELL DEATH; CELL SURFACE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; GENE EXPRESSION PROFILING; GENE LOCUS; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE ACTIVATION; MICROBIAL ACTIVITY; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; TARGET CELL; UTERINE CERVIX CARCINOMA; WART VIRUS;

BLOTTING, WESTERN; GENE EXPRESSION PROFILING; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICROSCOPY, CONFOCAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 70449368140     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939502     Document Type: Article

References (45)

1. Raulet, D. H., Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 2003. 3: 781-790.
2. Groh, V., Bruhl, A., El-Gabalawy, H., Nelson, J. L. and Spies, T., Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 2003. 100: 9452-9457.
3. Saez-Borderias, A., Guma, M., Angulo, A., Bellosillo, B., Pende, D. and Lopez-Botet, M., Expression and function of NKG2D in CD4+ T cells specific for human cytomegalovirus. Eur. J. Immunol. 2006. 36: 3198-3206.
4. Wu, J., Y., S., Bakker, A. B., Bauer, S., Spies, T., Lanier, L. L. and Phillips, J. H., An activating immunoreceptor complex formed by NKG2D and DAP10. Science 1999. 285: 730-732. (Pubitemid 129505075)
5. Gilfillan, S., Ho, E. L., Cella, M., Yokoyama, W. M. and Colonna, M., NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Nat. Immunol. 2002. 3: 1150-1155.
6. Diefenbach, A., Tomasello, E., Lucas, M., Jamieson, A. M., Hsia, J. K., Vivier, E. and Raulet, D. H., Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat. Immunol. 2002. 3: 1142-1149.
7. Bryceson, Y. T., March, M. E., Ljunggren, H. G. and Long, E. O., Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 2006. 107: 159-166.
8. Horng, T., Bezbradica, J. S. and Medzhitov, R., NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway. Nat. Immunol. 2007. 8: 1289-1291.
9. Eagle, R. A. and Trowsdale, J., Promiscuity and the single receptor: NKG2D. Nat. Rev. Immunol. 2007. 7: 737-744.
10. Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L. and Spies, T., Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999. 285: 727-729. (Pubitemid 129505074)
11. Cosman, D., Mullberg, J., Sutherland, C. L., Chin, W., Armitage, R., Fanslow, W., Kubin, M. and Chalupny, N. J., ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 2001. 14: 123-133. (Pubitemid 32206515)
12. Chalupny, N., Sutherland, C., Lawrence, W., Rein-Weston, A. and Cosman, D., ULBP4 is a novel ligand for human NKG2D. Biochem. Biophys. Res. Commun. 2003. 305: 129-135.
13. Bacon, L., Eagle, R. A., Meyer, M., Easom, N., Young, N. T. and Trowsdale, J., Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D. J. Immunol. 2004. 173: 1078-1084. (Pubitemid 38924282)
14. Cerwenka, A., Bakker, A. B., McClanahan, T., Wagner, J., Wu, J., Phillips, J. H. and Lanier, L. L., Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 2000. 12: 721-727.
15. Diefenbach, A., Jamieson, A. M., Liu, S. D., Shastri, N. and Raulet, D. H., Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 2000. 1: 119-126.
16. Carayannopoulos, L. N., Naidenko, O. V., Fremont, D. H. and Yokoyama, W. M., Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J. Immunol. 2002. 169: 4079-4083.
17. Takada, A., Yoshida, S., Kajikawa, M., Miyatake, Y., Tomaru, U., Sakai, M., Chiba, H. et al. Two novel NKG2D ligands of the mouse H60 family with differential expression patterns and binding affinities to NKG2D. J. Immunol. 2008. 180: 1678-1685.
18. Diefenbach, A., Jensen, E. R., Jamieson, A. M. and Raulet, D. H., Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 2001. 413: 165-171. (Pubitemid 32867877)
19. Cerwenka, A., Baron, J. L. and Lanier, L. L., Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc. Natl. Acad. Sci. USA 2001. 98: 11521-11526.
20. Guerra, N., Tan, Y. X., Joncker, N. T., Choy, A., Gallardo, F., Xiong, N., Knoblaugh, S. et al. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity 2008. 28: 492-494.
21. Lanier, L. L., Evolutionary struggles between NK cells and viruses. Nat. Rev. Immunol. 2008. 8: 259-268.
22. Gleimer, M. and Parham, P., Stress management: MHC class I and class Ilike molecules as reporters of cellular stress. Immunity 2003. 19: 469-477. (Pubitemid 37311429)
23. López-Larrea, C., Suárez-Alvarez, B., López-Soto, A., López-Vázquez, A. and Gonzalez, S., The NKG2D receptor: sensing stressed cells. Trends Mol. Med. 2008. 14: 179-189.
24. Eagle, R. A., Jafferji, I. and Barrow, A. D., Beyond stressed self: evidence for NKG2D ligand expression on healthy cells. Curr. Immunol. Rev. 2009. 5: 22-34.
25. Rabinovich, B. A., Li, J., Shannon, J., Hurren, R., Chalupny, J., Cosman, D. and Miller, R. G., Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells. J. Immunol. 2003. 170: 3572-3576. (Pubitemid 36359224)
26. Molinero, L. L., Fuertes, M. B., Rabinovich, G. A., Fainboim, L. and Zwirner, N. W., Activation-induced expression of MICA on T lymphocytes involves engagement of CD3 and CD28. J. Leukoc. Biol. 2002. 71: 791-797.
27. Cerboni, C., Zingoni, A., Cippitelli, M., Piccoli, M., Frati, L. and Santoni, A., Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis. Blood 2007. 110: 606-615.
28. Groh, V., Bahram, S., Bauer, S., Herman, A., Beauchamp, M. and Spies, T., Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc. Natl. Acad. Sci. USA 1996. 93: 12445-12450.
29. Eagle, R. A., Flack, G., Warford, A., Martinez-Borra, J., Jafferji, I., Traherne, J. A., Ohashi, M. et al. Cellular expression, trafficking, and function of two isoforms of human ULBP5/RAET1G. PLoS ONE 2009. 4: e4503.
30. Borchers, M. T., Harris, N. L., Wesselkamper, S. C., Vitucci, M. and Cosman, D., NKG2D ligands are expressed on stressed human airway epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 2006. 291: L222-L231.
31. Boissel, N., Rea, D., Tieng, V., Dulphy, N., Brun, M., Cayuela, J. M., Rousselot, P. et al. BCR/ABL oncogene directly controls MHC class I chain-related molecule A expression in chronic myelogenous leukemia. J. Immunol. 2006. 176: 5108-5116.
32. Eagle, R. A., Traherne, J. A., Ashiru, O., Wills, M. R. and Trowsdale, J., Regulation of NKG2D ligand gene expression. Hum. Immunol. 2006. 67: 159-169.
33. Radosavljevic, M., Cuillerier, B., Wilson, M. J., Clement, O., Wicker, S., Gilfillan, S., Beck, S. et al., A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3. Genomics 2002. 79: 114-123. (Pubitemid 34112073)
34. McFarland, B. J. and Strong, R. K., Thermodynamic analysis of degenerate recognition by the NKG2D immunoreceptor: not induced fit but rigid adaptation. Immunity 2003. 19: 803-812.
35. O'Callaghan, C. A., Cerwenka, A., Willcox, B. E., Lanier, L. L. and Bjorkman, P. J., Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60. Immunity 2001. 15: 201-211. (Pubitemid 32816870)
36. Sutherland, C. L., Chalupny, N. J., Schooley, K., VandenBos, T., Kubin, M. and Cosman, D., UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells. J. Immunol. 2002. 168: 671-679. (Pubitemid 34049567)
37. Suemizu, H., Radosavljevic, M., Kimura, M., Sadahiro, S., Yoshimura, S., Bahram, S. and Inoko, H., A basolateral sorting motif in the MICA cytoplasmic tail. Proc. Natl. Acad. Sci. USA 2002. 99: 2971-2976.
38. Pende, D., Rivera, P., Marcenaro, S., Chang, C. C., Biassoni, R., Conte, R., Kubin, M. et al. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res. 2002. 62: 6178-6186. (Pubitemid 35244469)
39. Schrambach, S., Ardizzone, M., Leymarie, V., Sibilia, J. and Bahram, S., In vivo expression pattern of MICA and MICB and its relevance to autoimmunity and cancer. PLoS ONE 2007. 2: e518.
40. Apps, R., Gardner, L., Traherne, J., Male, V. and Moffett, A., Natural-killer cell ligands at the maternal-fetal interface: UL-16 binding proteins, MHC class-I chain related molecules, HLA-F and CD48. Hum. Reprod. 2008. 23:2535-2548.
41. Collins, R. W. M., Human MHC class I chain related (MIC) genes: their biological function and relevance to disease and transplantation. Eur. J. Immunogenet. 2004. 31: 105-114.
42. Salih, H. R., Holdenrieder, S. and Steinle, A., Soluble NKG2D ligands: prevalence, release, and functional impact. Front Biosci. 2008. 13: 3448-3456. (Pubitemid 351594695)
43. Barber, A., Zhang, T., DeMars, L. R., Conejo-Garcia, J., Roby, K. F. and Sentman, C. L., Chimeric NKG2D receptor-bearing T cells as immunotherapy for ovarian cancer. Cancer Res. 2007. 67: 5003-5008. (Pubitemid 46910210)
44. McGilvray, R. W., Eagle, R. A., Watson, N. F., Ball, G., Jafferji, I., Trowsdale, J. and Durrant, L. G., A comprehensive analysis of NKG2D ligand expression in colorectal cancer patients reveals combinatorial associations with prognosis and evidence for immunoediting. Clin Cancer Res. 2009, in press.
45. Thomas, M., Boname, J. M., Field, S., Nejentsev, S., Salio, M., Cerundolo, V., Wills, M. and Lehner, P. J., Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity. Proc. Natl. Acad. Sci. USA 2008. 105: 1656-1661.